Over the 52 week study period, the safety profile of CAM2029 was found to be consistent with first generation somatostatin ...
A Prescription Drug User Fee Act target date of December 20, 2024 has been set for the resubmitted application. The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug ...
A packaging error has prompted the recall of 1 lot of Endo’s Clonazepam Orally Disintegrating Tablets. The product is being recalled because the incorrect strength of 0.125mg is appearing on the ...
Significantly reduced rate of acne and rosacea seen in patients treated with CGRPi mAbs versus triptans, topiramate ...
Findings from a phase 2 trial show Lomecel-B prevents cognitive decline and improves quality of life in patients with mild Alzheimer disease. The Food and Drug Administration (FDA) has granted Fast ...
No significant increase seen with use of GLP-1 RAs vs SGLT2is or DPP4is among older Medicare beneficiaries. HealthDay News — For older adults with type 2 diabetes (T2D), use of glucagon-like peptide 1 ...
The personalized immunotherapy is developed using autologous dendritic cells loaded with pancreatic adenocarcinoma lysate and ...
During the omicron era, hospital-onset SARS-CoV-2 infection remained associated with increased morbidity and mortality, ...
Metformin displayed lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had highest risk ...
Stiff person syndrome is a rare autoimmune neurological disorder that causes progressive muscle stiffness in the torso, arms, ...
Some countries that experienced conflict, such as Ukraine, had initial dips in immunization coverage but did not see an ...
The company said the tests would be offered for free. If a patient tests positive, Providence will reach out to discuss next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback